Xgeva
Top stories
Latest
- Teva's Degevma Wins FDA Approval, Joining a Crowded Field of Xgeva Biosimilars for Cancer That Reaches Bonemedicaldaily.com · 2026-10-02 00:10 UTC · 2 more reports
- Teva Pharmaceutical Industries Ltd: Teva Continues Biosimilar Momentum with U.S. FDA Approval of DEGEVMA (denosumab-adet), a Biosimilar to Xgeva (denosumab)finanznachrichten.de · 2026-09-28 20:37 UTC · 1 more reports